In our work, we targeted ESAT-6 to DEC205+ APCs (α-DEC-ESAT) and tested the in vivo effects upon cellular immune responses (IFN-γ production, in vivo CTL killing rate and lung Mtb clearance) during experimental pulmonary tuberculosis. The gene discussed is IFNG; the disease is pulmonary tuberculosis.